Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Hagemeister, FB' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 83 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Visco, C; Medeiros, LJ; Mesina, OM; Rodriguez, MA; Hagemeister, FB; McLaughlin, P; Romaguera, JE; Cabanillas, F; Sarris, AH
      Non-Hodgkin's lymphoma affecting the testis: Is it curable with doxorubicin-based therapy?

      CLINICAL LYMPHOMA
    2. Tsimberidou, AM; Sarris, AH; Medeiros, LJ; Mesina, O; Rodriguez, MA; Hagemeister, FB; Romaguera, J; Pro, B; McLaughlin, P; Dang, N; Cabanillas, F
      Hodgkin's disease in patients infected with human immunodeficiency virus: Frequency, presentation and clinical outcome

      LEUKEMIA & LYMPHOMA
    3. Younes, A; Preti, HA; Hagemeister, FB; McLaughlin, P; Romaguera, JE; Rodriguez, MA; Samuels, BI; Palmer, JL; Cabanillas, F
      Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

      ANNALS OF ONCOLOGY
    4. Hagemeister, FB; Diehl, V
      The role of ifosfamide in cytoreduction, stem cell mobilization and high-dose therapy in relapsed/refractory malignant lymphomas

      EUROPEAN JOURNAL OF HAEMATOLOGY
    5. Hagemeister, FB; Donato, M
      Ifosfamide-based chemotherapy regimens in treatment of lymphoma: the M.D. Anderson experience

      EUROPEAN JOURNAL OF HAEMATOLOGY
    6. Sarris, AH; Braunschweig, I; Medeiros, LJ; Duvic, M; Ha, CS; Rodriguez, MA; Hagemeister, FB; McLaughlin, P; Romaguera, J; Cox, J; Cabanillas, F
      Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: Preferential cutaneous relapses but high cure rate with doxorubicin-based therapy

      JOURNAL OF CLINICAL ONCOLOGY
    7. Rodriguez, J; Munsell, M; Yazji, S; Hagemeister, FB; Younes, A; Andersson, B; Giralt, S; Gajewski, J; de Lima, M; Couriel, D; Romaguera, J; Cobanillas, FF; Champlin, RE; Khouri, IF
      Impact of high-dose chemotherapy on peripheral T-cell lymphomas

      JOURNAL OF CLINICAL ONCOLOGY
    8. Khouri, IF; Saliba, RM; Giralt, SA; Lee, MS; Okoroji, GJ; Hagemeister, FB; Korbling, M; Younes, A; Ippoliti, C; Gajewski, JL; McLaughlin, P; Anderlini, P; Donato, ML; Cabanillas, FF; Champlin, RE
      Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

      BLOOD
    9. Younes, A; Cristofanilli, M; McLaughlin, P; Hagemeister, FB; Weber, D; Mesina, O; Cabanillas, F
      Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    10. Romaguera, JE; Khouri, IF; Kantarjian, HM; Hagemeister, FB; Rodriguez, MA; McLaughlin, P; Sarris, AH; Younes, A; Rodriguez, J; Cabanillas, F
      Untreated aggressive mantle cell lymphoma: Results with intensive chemotherapy without stem cell transplant in elderly patients

      LEUKEMIA & LYMPHOMA
    11. Dubey, P; Wilson, G; Mathur, KK; Hagemeister, FB; Fuller, LM; Ha, CS; Cox, JD; Meistrich, ML
      Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP)

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    12. McLaughlin, P; Hagemeister, FB; Rodriguez, MA; Sarris, AH; Pate, O; Younes, A; Lee, MS; Dang, NH; Romaguera, JE; Preti, AH; McAda, N; Cabanillas, F
      Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma

      SEMINARS IN ONCOLOGY
    13. Hagemeister, FB
      The role of ifosfamide in the treatment of lymphomas

      LEUKEMIA & LYMPHOMA
    14. Sarris, AH; Kliche, KO; Pethambaram, P; Preti, A; Tucker, S; Jackow, C; Messina, O; Pugh, W; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, J; Fritsche, H; Witzig, T; Duvic, M; Andreeff, M; Cabanillas, F
      Interleukin-10 levels are often elevated in serum of adults with Hodgkin'sdisease and are associated with inferior failure-free survival

      ANNALS OF ONCOLOGY
    15. Thomas, DA; Cortes, J; O'Brien, S; Pierce, S; Faderl, S; Albitar, M; Hagemeister, FB; Cabanillas, FF; Murphy, S; Keating, MJ; Kantarjian, H
      Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    16. Ha, CS; Kavadi, V; Dimopoulos, MA; Hagemeister, FB; Osborne, BM; Fuller, LM; Smith, TL; Hess, MA; McLaughlin, PW; Cabanillas, FF; Cox, JD
      Hodgkin's disease with lymphocyte predominance: Long-term results based oncurrent histopathologic criteria

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    17. Romaguera, JE; Rodriguez, MA; Hagemeister, FB; McLaughlin, P; Rodriguez, J; Preti, A; Younes, A; Sarris, AH; Cabanillas, F
      Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/Mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination

      INVESTIGATIONAL NEW DRUGS
    18. McLaughlin, P; Hagemeister, FB; Grillo-Lopez, AJ
      Rituximab in indolent lymphoma: The single-agent pivotal trial

      SEMINARS IN ONCOLOGY
    19. Rodriguez, J; McLaughlin, P; Hagemeister, FB; Fayad, L; Rodriguez, MA; Santiago, M; Hess, M; Romaguera, J; Cabanillas, F
      Follicular large cell lymphoma: An aggressive lymphoma that often presentswith favorable prognostic features

      BLOOD
    20. Rodriguez, J; Rodriguez, MA; Fayad, L; McLaughlin, P; Swan, F; Sarris, A; Romaguera, J; Andersson, B; Cabanillas, F; Hagemeister, FB
      ASHAP: A regimen for cytoreduction of refractory or recurrent Hodgkin's disease

      BLOOD
    21. Steinbach, G; Ford, R; Glober, G; Sample, D; Hagemeister, FB; Lynch, PM; McLaughlin, PW; Rodriguez, MA; Romaguera, JE; Sarris, AH; Younes, A; Luthra, R; Manning, JT; Johnson, CM; Lahoti, S; Shen, Y; Lee, JE; Winn, RJ; Genta, RM; Graham, DY; Cabanillas, FF
      Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue - An uncontrolled trial

      ANNALS OF INTERNAL MEDICINE
    22. ROMAGUERA JE; DIAZPAVON JR; CARIAS L; HAGEMEISTER FB; MCLAUGHLIN P; RODRIGUEZ MA; SARRIS AH; YOUNES A; PRETI A; BACHIER C; LLERENA E; CABANILLAS F
      USE OF THE INTERNATIONAL PROGNOSTIC INDEX AND THE TUMOR SCORE TO DETECT POOR-RISK PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA -A STUDY OF 37 PREVIOUSLY UNTREATED PATIENTS

      Leukemia & lymphoma
    23. Romaguera, JE; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Bachier, C; Preti, H; Sarris, AH; Weber, D; Younes, A; Cabanillas, F
      Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesnaand consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    24. CABANILLAS F; PAVON JRD; HAGEMEISTER FB; MCLAUGHLIN P; RODRIGUEZ MA; ROMAGUERA JE; DONG K; MOON T
      ALTERNATING TRIPLE THERAPY FOR THE TREATMENT OF INTERMEDIATE GRADE AND IMMUNOBLASTIC LYMPHOMA

      Annals of oncology
    25. LIAO ZX; HA CS; FULLER LM; HAGEMEISTER FB; CABANILLAS F; TUCKER SL; HESS MA; COX JD
      SUBDIAPHRAGMATIC STAGE-I AND STAGE-II HODGKINS-DISEASE - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS

      International journal of radiation oncology, biology, physics
    26. FULLER LM; MIRZA NQ; PALMER JL; DAVIS BR; HA CS; RODRIGUEZ MA; HAGEMEISTER FB; CABANILLAS F; MCLAUGHLIN P; BUTLER JJ; NORTH LB; MARTIN RG
      HODGKINS-DISEASE - CORRELATION OF CLINICAL CHARACTERISTICS WITH PROBABILITIES FOR NEGATIVE LYMPHANGIOGRAM VS. NEGATIVE LAPAROTOMY FINDINGS IN PATIENTS WITH STAGE-I SUPRADIAPHRAGMATIC PRESENTATIONS VS. THOSE INPATIENTS WITH STAGE-II

      International journal of radiation oncology, biology, physics
    27. BOUVET M; STAERKEL GA; SPITZ FR; CURLEY SA; CHARNSANGAVEJ C; HAGEMEISTER FB; JANJAN NA; PISTERS PWT; EVANS DB
      PRIMARY PANCREATIC LYMPHOMA

      Surgery
    28. VLACHAKI MT; HA CS; HAGEMEISTER FB; FULLER LM; RODRIGUEZ MA; HESS MA; TUCKER SL; CABANILLAS F; COX JD
      STAGE-I HODGKIN DISEASE - RADIATION-THERAPY AND CHEMOTHERAPY AT THE UNIVERSITY-OF-TEXAS M.D.-ANDERSON-CANCER-CENTER, 1967-1997

      Radiology
    29. ROBBINS WA; MEISTRICH ML; MOORE D; HAGEMEISTER FB; WEIER HU; CASSEL MJ; WILSON G; ESKENAZI B; WYROBEK AJ
      CHEMOTHERAPY INDUCES TRANSIENT SEX CHROMOSOMAL AND AUTOSOMAL ANEUPLOIDY IN HUMAN SPERM

      Nature genetics
    30. YOUNES A; RODRIGUEZ MA; MCLAUGHLIN P; NORTH L; SARRIS AH; PATE O; HAGEMEISTER FB; ROMAGUERA J; PRETI A; BACHIER C; CABANILLAS F
      PHASE-I STUDY OF FLUDARABINE AND PACLITAXEL FOR THE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMA

      Leukemia & lymphoma
    31. MEISTRICH ML; WILSON G; MATHUR K; FULLER LM; RODRIGUEZ MA; MCLAUGHLIN P; ROMAGUERA JE; CABANILLAS FF; HA CS; LIPSHULTZ LI; HAGEMEISTER FB
      RAPID RECOVERY OF SPERMATOGENESIS AFTER MITOXANTRONE, VINCRISTINE, VINBLASTINE, AND PREDNISONE CHEMOTHERAPY FOR HODGKINS-DISEASE

      Journal of clinical oncology
    32. VLACHAKI MT; HA CS; HAGEMEISTER FB; FULLER LM; RODRIGUEZ MA; BESA PC; HESS MA; BROWN B; CABANILLAS F; COX JD
      LONG-TERM OUTCOME OF TREATMENT FOR ANN-ARBOR STAGE-1 HODGKINS-DISEASE- PATTERNS OF FAILURE, LATE TOXICITY AND 2ND MALIGNANCIES

      International journal of radiation oncology, biology, physics
    33. LIAO ZX; HA CS; FULLER LM; HAGEMEISTER FB; CABANILLAS F; TUCKER SL; HESS MA; COX JD
      SUBDIAPHRAGMATIC STAGE-I AND STAGE-II HODGKINS-DISEASE - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS

      International journal of radiation oncology, biology, physics
    34. VLACHAKI MT; HAGEMEISTER FB; FULLER LM; BESA PC; HESS MA; BROWN B; CABANILLAS F; COX JD
      LONG-TERM OUTCOME OF TREATMENT FOR ANN-ARBOR STAGE-I HODGKINS-DISEASE- PROGNOSTIC FACTORS FOR SURVIVAL AND FREEDOM FROM PROGRESSION

      International journal of radiation oncology, biology, physics
    35. HAGEMEISTER FB; HA C; ROMAGUERA J; MCLAUGHLIN P; RODRIGUEZ A; YOUNES A; SARRIS A; CABANILLAS F; TUCKER S; HESS M; COX J
      THE POST-THERAPY GALLIUM SCAN (GS) IN CLINICALLY STAGED SUPRADIAPHRAGMATIC I-II HODGKINS-DISEASE (HD) IS THE MOST IMPORTANT PREDICTOR OF FREEDOM FROM PROGRESSION (FFP)

      Blood
    36. ROMAGUERA J; KHOURI I; HAGEMEISTER FB; RODRIGUEZ MA; MCLAUGHLIN P; SARRIS A; YOUNES A; KEATING MJ; KOLLER C; OBRIEN S; RIGGS S; KANTARJIAN H; CHAMPLIN R; CABANILLAS F
      HCVAD ARA-C-MTX (HCVAD/A-M) WITH OR WITHOUT HIGH-DOSE CHEMOTHERAPY AND STEM-CELL TRANSFUSION (SCT) AS SALVAGE FOR RELAPSED OR REFRACTORY DIFFUSE/MODULAR MANTLE CELL LYMPHOMA (MCL)/

      Blood
    37. ROMAGUERA J; HAGEMEISTER FB; MCLAUGHLIN P; RODRIGUEZ MA; BACHIER C; PRETI H; SARRIS AH; WEBER D; YOUNES A; CABANILLAS F
      PHASE-II STUDY OF TAXOL IN COMBINATION WITH MITOXANTRONE AND IFOSFAMIDE (MINT) WITH CONSOLIDATION ESHAP FOR LYMPHOMAS

      Blood
    38. CABANILLAS F; ROMAGUERA J; HAGEMEISTER FB; YOUNES A; MCLAUGHLIN P; SARRIS A; RODRIGUEZ MA
      RANDOMIZED STUDY OF IDARBUBICIN (IDA) VS ADRIAMYCIN (ADRIA)-BASED COMBINATION CHEMOTHERAPY FOR AGGRESSIVE POOR-PROGNOSIS (TUMOR SCORE GREATER-THAN-OR-EQUAL-TO-3) NON-HODGKINS-LYMPHOMAS (APPNHL)

      Blood
    39. SEYMOUR JF; TALPAZ M; HAGEMEISTER FB; CABANILLAS F; KURZROCK R
      CLINICAL CORRELATES OF ELEVATED SERUM LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH UNTREATED HODGKINS-DISEASE

      The American journal of medicine
    40. HAGEMEISTER FB
      HODGKINS-DISEASE - THE NEXT DECADE

      Leukemia & lymphoma
    41. SEYMOUR JF; MCLAUGHLIN P; FULLER LM; HAGEMEISTER FB; HESS M; SWAN F; ROMAGUERA J; RODRIGUEZ MA; BESA P; COX J; CABANILLAS F
      HIGH-RATE OF PROLONGED REMISSIONS FOLLOWING COMBINED-MODALITY THERAPYFOR PATIENTS WITH LOCALIZED LOW-GRADE LYMPHOMA

      Annals of oncology
    42. YOUNES A; CABANILLAS F; MCLAUGHLIN PW; HAGEMEISTER FB; FARBER C; SARRIS A; PATE O; MYERS J; PORTLOCK C
      PRELIMINARY EXPERIENCE WITH PACLITAXEL FOR THE TREATMENT OF RELAPSED AND REFRACTORY HODGKINS-DISEASE

      Annals of oncology
    43. HAGEMEISTER FB
      TREATMENT OF SMALL NON-CLEAVED CELL LYMPHOMA IN THE ADULT

      Biomedicine & pharmacotherapy
    44. MCLAUGHLIN P; HAGEMEISTER FB; ROMAGUERA JE; SARRIS AH; PATE O; YOUNES A; SWAN F; KEATING M; CABANILLAS F
      FLUDARABINE, MITOXANTRONE, AND DEXAMETHASONE - AN EFFECTIVE NEW REGIMEN FOR INDOLENT LYMPHOMA

      Journal of clinical oncology
    45. YOUNES A; AYOUB JP; HAGEMEISTER FB; MCLAUGHLIN P; SARRIS A; RODRIGUEZ MA; SWAN F; ROMAGUERA JE; MARTIN J; CABANILLAS F
      NO EFFECT OF 96-HOUR PACLITAXEL INFUSION IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA REFRACTORY TO A 3-HOUR INFUSION SCHEDULE

      Journal of clinical oncology
    46. MOORE DF; PRETI A; TRAN SM; HAGEMEISTER FB; RODRIGUEZ MA; MCLAUGHLIN P; ROMAGUERA J; SARRIS A; YOUNES A; MOORE DF; CABANILLAS F
      PROGNOSTIC IMPLICATIONS FOLLOWING AN INDETERMINATE NONDIAGNOSTIC WORK-UP OF LYMPHOMA

      Blood
    47. ROMAGUERA J; KHOURI I; KANTARJIAN H; TEROLCASTERA MJ; RODRIGUEZ MA; HAGEMEISTER FB; MCLAUGHLIN P; YOUNES A; SARRIS A; BACHIER C; PRETI HA; PUGH W; GARCIACONDE J; CHAMPLIN R; CABANILLAS F
      HCVAD MTX-ARAC - A NEW EFFECTIVE REGIMEN FOR DIFFUSE AND NODULAR MANTLE CELL LYMPHOMA (MCL)/

      Blood
    48. HAGEMEISTER FB
      LOW-GRADE LYMPHOMAS - NEW ENTITIES AND TREATMENT CONCEPTS

      Medical oncology
    49. SUKI S; SWAN F; TUCKER S; FRITSCHE HA; REDMAN JR; RODRIGUEZ MA; MCLAUGHLIN P; ROMAGUERA J; HAGEMEISTER FB; VELASQUEZ WS; SARRIS AH; YOUNES A; CABANILLAS F
      RISK CLASSIFICATION FOR LARGE-CELL LYMPHOMA USING LACTATE-DEHYDROGENASE, BETA-2-MICROGLOBULIN, AND THYMIDINE KINASE

      Leukemia & lymphoma
    50. RODRIGUEZ MA; CABANILLAS FC; HAGEMEISTER FB; MCLAUGHLIN P; ROMAGUERA JE; SWAN F; VELASQUEZ W
      A PHASE-II TRIAL OF MESNA IFOSFAMIDE, MITOXANTRONE AND ETOPOSIDE FOR REFRACTORY LYMPHOMAS

      Annals of oncology
    51. RODRIGUEZ MA; CABANILLAS FC; VELASQUEZ W; HAGEMEISTER FB; MCLAUGHLIN P; SWAN F; ROMAGUERA JE
      RESULTS OF A SALVAGE TREATMENT PROGRAM FOR RELAPSING LYMPHOMA - MINE CONSOLIDATED WITH ESHAP

      Journal of clinical oncology
    52. FULLER LM; KRASIN MJ; VELASQUEZ WS; ALLEN PK; MCLAUGHLIN P; RODRIGUEZ MA; HAGEMEISTER FB; SWAN F; CABANILLAS F; PALMER JL; COX JD
      SIGNIFICANCE OF TUMOR SIZE AND RADIATION-DOSE TO LOCAL-CONTROL IN STAGE I-III DIFFUSE LARGE-CELL LYMPHOMA TREATED WITH CHOP-BLEO AND RADIATION

      International journal of radiation oncology, biology, physics
    53. DIAZPAVON JR; CABANILLAS F; MAJLIS A; HAGEMEISTER FB
      OUTCOME OF HODGKINS-DISEASE IN ELDERLY PATIENTS

      Hematological oncology
    54. STEINBACH G; CABANILLAS FF; PUGH W; GENTA R; GLOBER G; HAGEMEISTER FB; MCLAUGHLIN PW; RODRIGUEZ MA; ROMAGUERA JE; SARRIS AH; YOUNES A; JOHNSON C; KONISHI H; LYNCH PM; ROUBEIN LD; FORD R; GRAHAM DY; LEVIN B
      ANTIBIOTIC-TREATMENT TRIAL OF GASTRIC MALT LYMPHOMA

      Gastroenterology
    55. HAGEMEISTER FB; MCLAUGHLIN P; RODRIGUEZ MA; COX JD; HA CS; ROMAGUERA JE; SARRIS A; YOUNES A; BACHIER C; PRETI A; CABANILLAS F
      THE PRETREATMENT SERUM BETA-2-MICROGLOBULIN (BETA(2)M) IS THE MOST IMPORTANT FEATURE PREDICTING FREEDOM FROM PROGRESSION (FFP) IN CLINICALLY STAGED (CS) I-II HODGKINS-DISEASE (HD) TREATED WITH NOVP AND EXTENDED FIELD RADIOTHERAPY

      Blood
    56. CABANILLAS F; LEE MS; MCLAUGHLIN P; HAGEMEISTER FB; COX JD; RODRIGUEZ MA; HA CS; ROMAGUERA JE; SARRIS A; YOUNES A
      EARLY ACHIEVEMENT OF MOLECULAR COMPLETE REMISSION (CR) ASSAYED BY PCRPREDICTS FAILURE FREE SURVIVAL (FFS) IN LOW-GRADE FOLLICULAR LYMPHOMAS (LGFL)

      Blood
    57. HAGEMEISTER FB
      HODGKINS-DISEASE - CHALLENGES IN DIAGNOSIS, STAGING, AND TREATMENT

      Diagnostic oncology
    58. RODRIGUEZ J; PUGH WC; ROMAGUERA JE; LUTHRA R; HAGEMEISTER FB; MCLAUGHLIN P; RODRIGUEZ MA; SWAN F; CABANILLAS F
      PRIMARY MEDIASTINAL LARGE-CELL LYMPHOMA IS CHARACTERIZED BY AN INVERTED PATTERN OF LARGE TUMORAL MASS AND LOW BETA(2) MICROGLOBULIN LEVELS IN SERUM AND FREQUENTLY ELEVATED LEVELS OF SERUM LACTATE-DEHYDROGENASE

      Annals of oncology
    59. HAGEMEISTER FB; KHETAN R; ALLEN P; MCLAUGHLIN P; RODRIGUEZ MA; SWAN F; ROMAGUERA JE; CABANILLAS F
      STAGE, SERUM LDH, AND PERFORMANCE STATUS PREDICT DISEASE PROGRESSION AND SURVIVAL IN HIV-ASSOCIATED LYMPHOMAS

      Annals of oncology
    60. HAGEMEISTER FB; PURUGGANAN R; PODOLOFF DA; HESS M; RODRIGUEZ MA; MCLAUGHLIN P; SWAN F; ROMAGUERA JE; CABANILLAS F
      THE GALLIUM SCAN PREDICTS RELAPSE IN PATIENTS WITH HODGKINS-DISEASE TREATED WITH COMBINED-MODALITY THERAPY

      Annals of oncology
    61. MCLAUGHLIN P; HAGEMEISTER FB; SWAN F; CABANILLAS F; ROMAGUERA J; RODRIGUEZ MA; LEE MS; PATE O; SARRIS A; YOUNES A
      INTENSIVE CONVENTIONAL-DOSE CHEMOTHERAPY FOR STAGE-IV LOW-GRADE LYMPHOMA - HIGH REMISSION RATES AND REVERSION TO NEGATIVE OF PERIPHERAL-BLOOD BCL-2 REARRANGEMENT

      Annals of oncology
    62. PRETI A; HAGEMEISTER FB; MCLAUGHLIN P; SWAN F; RODRIGUEZ A; BESA P; COX JD; ALLEN PK; CABANILLAS F
      HODGKINS-DISEASE WITH A MEDIASTINAL MASS GREATER-THAN 10 CM - RESULTSOF 4 DIFFERENT TREATMENT APPROACHES

      Annals of oncology
    63. VELASQUEZ WS; MCLAUGHLIN P; TUCKER S; HAGEMEISTER FB; SWAN F; RODRIGUEZ MA; ROMAGUERA J; RUBENSTEIN E; CABANILLAS F
      ESHAP - AN EFFECTIVE CHEMOTHERAPY REGIMEN IN REFRACTORY AND RELAPSINGLYMPHOMA - A 4-YEAR FOLLOW-UP-STUDY

      Journal of clinical oncology
    64. MCLAUGHLIN P; HAGEMEISTER FB; SWAN F; CABANILLAS F; PATE O; ROMAGUERA JE; RODRIGUEZ MA; REDMAN JR; KEATING M
      PHASE-I STUDY OF THE COMBINATION OF FLUDARABINE, MITOXANTRONE, AND DEXAMETHASONE IN LOW-GRADE LYMPHOMA

      Journal of clinical oncology
    65. ROMAGUERA JE; RODRIGUEZ MA; HAGEMEISTER FB; MCLAUGHLIN P; SWAN F; MOORE DF; SARRIS AH; YOUNES A; HILL D; CABANILLAS F
      A PHASE-II TRIAL OF ORAL ETOPOSIDE WITH MITOXANTRONE AND IFOSFAMIDE MESNA CONSOLIDATED WITH INTRAVENOUS ETOPOSIDE, METHYLPREDNISOLONE, HIGH-DOSE ARABINOSIDE, AND CISPLATIN AS SALVAGE THERAPY FOR RELAPSING AND OR REFRACTORY LYMPHOMAS/

      Investigational new drugs
    66. KIM EE; GARCIA JR; WONG FCL; HAGEMEISTER FB; WONG WH; HAYNIE TP; YANG DJ; PODOLOFF DA
      DIFFERENTIATION OF BONE LYMPHOMA FROM POSTTREATMENT CHANGES USING PETWITH F-18 FDG

      The Journal of nuclear medicine
    67. GARCIA JR; KIM EE; WONG FCL; HAGEMEISTER FB; HAYNIE TP; WONG WH; YANG DJ; PODOLOFF DA
      GA-67-CITRATE SCAN IN THE DIFFERENTIATION OF BONE LYMPHOMA FROM POSTTREATMENT CHANGES - COMPARISON WITH FDG-PET SCAN

      The Journal of nuclear medicine
    68. HAGEMEISTER FB; PURUGGANAN R; FULLER L; MCLAUGHLIN P; SWAN F; ROMAGUERA J; RODRIGUEZ M; CABANILLAS F
      TREATMENT OF EARLY STAGES OF HODGKINS-DISEASE WITH NOVANTRONE, VINCRISTINE, VINBLASTINE, PREDNISONE, AND RADIOTHERAPY

      Seminars in hematology
    69. VELASQUEZ WS; MCLAUGHLIN P; FULLER LM; ALLEN PK; TUCKER SL; SWAN F; RODRIGUEZ MA; HAGEMEISTER FB; CABANILLAS FF
      INTERMEDIATE-GRADE LYMPHOMAS TREATED WITH AMIDE-DOXORUBICIN-VINCRISTINE-PREDNISONE-BLEOMYCIN ALTERNATED WITH LOPHOSPHAMIDE-METHOTREXATE-ETOPOSIDE-DEXAMETHASONE - APPLICATION OF PROGNOSTIC MODELS TO DATA-ANALYSIS

      Cancer
    70. SEYMOUR JR; GAGEL RF; HAGEMEISTER FB; CABANILLAS F
      DYSREGULATED VITAMIN-D METABOLISM IS COMMON IN NORMOCALCEMIC PATIENTSWITH UNTREATED HODGKINS-DISEASE

      Blood
    71. MOORE DF; HAGEMEISTER FB; RODRIGUEZ MA; ROMAGUERA JE; MCLAUGHLIN P; CABANILLAS F; FULLER L
      CLINICAL CHARACTERISTICS AND OUTCOME OF HODGKINS-DISEASE (HD) IN 125 PATIENTS (PT) 60 YEARS OF AGE AND OLDER

      Blood
    72. HAGEMEISTER FB; DUNLAVY K; CROW M; SANFORD D; KATZ R
      FINE-NEEDLE ASPIRATION (FNA) IN THE MANAGEMENT OF PATIENTS (PT) WITH HODGKINS-DISEASE (HD)

      Blood
    73. RODRIGUEZ MA; JENDIROBA D; CABANILLAS F; HAGEMEISTER FB; MCLAUGHLIN P; ROMAGUERA J; SWAN F; VELASQUEZ W
      CHARACTERISTICS OF LONG-TERM SURVIVORS (LTS) TREATED WITH SALVAGE CHEMOTHERAPY FOR LYMPHOMAS

      Blood
    74. FAHMY H; ANDERSSON BS; SAMUELS BI; SWAN F; HAGEMEISTER FB; GIRALT S; VANBESIEN K; MEHRA R; PRZEPIORKA D; GAJEWSKI J; KHOURI IF; BESA P; CABANILLAS F; CHAMPLIN RE
      RESPONSE TO A DOXORUBICIN HIGH-DOSE ARA-C AND CDDP-BASED REGIMEN (ASHAP) PREDICTS FOR LONG-TERM REMISSION AFTER AUTOLOGOUS MARROW TRANSPLANTATION (ABMT) IN ADVANCED HODGKINS-DISEASE (HD)

      Blood
    75. SEYMOUR JF; GAGEL RF; HAGEMEISTER FB; DIMOPOULOS MA; CABANILLAS F
      CALCITRIOL PRODUCTION IN HYPERCALCEMIC AND NORMOCALCEMIC PATIENTS WITH NON-HODGKIN-LYMPHOMA

      Annals of internal medicine
    76. LIANG JC; BAILEY NM; GABRIEL GJ; KATTAN MW; WANG RY; HAGEMEISTER FB; CABANILLAS FF; FULLER LM
      A NEW CHEMOTHERAPY REGIMEN FOR TREATMENT OF HODGKINS-DISEASE ASSOCIATED WITH MINIMAL GENOTOXICITY

      Leukemia & lymphoma
    77. ROBERTSON LE; HALL R; KEATING MJ; ESTEY E; KANTARJIAN HM; MCLAUGHLIN P; HAGEMEISTER FB; PLUNKETT W
      HIGH-DOSE CYTOSINE-ARABINOSIDE IN CHRONIC LYMPHOCYTIC-LEUKEMIA - A CLINICAL AND PHARMACOLOGICAL ANALYSIS

      Leukemia & lymphoma
    78. DIMOPOULOS MA; CABANILLAS F; LEE JJ; SWAN F; FULLER L; ALLEN PK; HAGEMEISTER FB
      PROGNOSTIC ROLE OF SERUM BETA(2)-MICROGLOBULIN IN HODGKINS-DISEASE

      Journal of clinical oncology
    79. LAREMORE DM; HAGEMEISTER FB; VASSILOPOULOUSELLIN R
      OVARIAN-FUNCTION AND FERTILITY AFTER CHEMOTHERAPY (NOVANTRONE, ONCOVIN, VINBLASTINE AND PREDNISONE-NOVP) AND RADIOTHERAPY (RT) FOR HODGKINS-DISEASE

      Clinical research
    80. SEYMOUR JF; HAGEMEISTER FB; DIMOPOULOS M; CABANILLAS F
      1,25-DIHYDROXYVITAMIN-D3 (CALCITRIOL) IS AN IMPORTANT MEDIATOR OF HYPERCALCEMIA IN PATIENTS (PTS) WITH NON-HODGKINS-LYMPHOMA (NHL) AND IS DYSREGULATED IN MANY NORMOCALCEMIC PTS

      Blood
    81. ROMAGUERA JE; RODRIGUEZ MA; HAGEMEISTER FB; MCLAUGHLIN P; SWAN F; SARRIS AH; YOUNES A; HILL D; CABANILLAS F
      A PHASE-II TRIAL OF ORAL VP-16 WITH MITOXANTRONE AND IFOSFAMIDE MESNAFOR SALVAGE OF RELAPSED OR REFRACTORY LYMPHOMA

      Blood
    82. SEYMOUR J; MCLAUGHLIN P; FULLER LM; HAGEMEISTER FB; HESS M; RODRIGUEZ MA; ROMAGUERA J; REDMAN J; SARRIS A; SWAN F; CABANILLAS F
      COMBINED-MODALITY THERAPY MAY CURE MOST PATIENTS WITH CLINICAL STAGE I AND II LOW-GRADE LYMPHOMA

      Blood
    83. SPINOLO JA; CABANILLAS F; DIXON DO; KHORANA SM; MCLAUGHLIN P; VELASQUEZ WS; HAGEMEISTER FB; REDMAN JR; SWAN F
      THERAPY OF RELAPSED OR REFRACTORY LOW-GRADE FOLLICULAR LYMPHOMAS - FACTORS ASSOCIATED WITH COMPLETE REMISSION, SURVIVAL AND TIME TO TREATMENT FAILURE

      Annals of oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 10:30:39